The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Estimated Market Size Of The Albumin Excipient Market During 2026–2030?
The albumin excipient market has shown robust expansion in recent years. It is projected to increase from $5.15 billion in 2025 to $5.47 billion in 2026, growing at a compound annual growth rate (CAGR) of 6.2%. Historically, this growth can be attributed to the rising demand for biologics, increased research in protein-based excipients, an uptick in pharmaceutical manufacturing, the adoption of recombinant albumin, and the development of stabilized formulations.
The albumin excipient market is anticipated to experience substantial growth over the coming years, with its size projected to reach $7.15 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.9%. This projected expansion during the forecast period is primarily driven by the expanding biopharmaceutical sector, advancements in protein excipient technology, the increasing occurrence of chronic diseases, a surge in contract manufacturing, and a rise in regulatory approvals for innovative drug formulations. Furthermore, significant trends anticipated in this period encompass innovations in protein stabilization, advancements in excipient formulation, improved drug delivery systems, adherence to regulatory compliance and GMP adoption, and optimization of the supply chain.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10672&type=smp
What Drivers Are Expected To Influence The Albumin Excipient Market During The Forecast Period?
The increasing incidence of chronic illnesses is anticipated to boost the expansion of the albumin excipient market in the future. Chronic diseases are defined as conditions that persist for at least three months and may worsen over time. Albumin functions as a blood volume expander and represents the most plentiful protein circulating within plasma. Furthermore, it serves as a versatile protein transporter for drug delivery, enhancing the pharmacokinetic characteristics of peptide or protein-based medications utilized in treating numerous ailments such as cancer and diabetes. For example, data from February 2024, published by the World Health Organization, a United Nations agency based in Switzerland, predicts that more than 35 million new cancer diagnoses are expected by 2050, signifying a 77% rise from the approximately 20 million cases estimated in 2022. Consequently, the growing occurrence of chronic diseases is a key factor driving the expansion of the albumin excipient market.
How Are The Various Segments Of The Albumin Excipient Market Categorized?
The albumin excipient market covered in this report is segmented –
1) By Product: Human Serum Albumin, Recombinant Albumin
2) By End-Users: Pharmaceutical And Biotechnology Industry, Research Institutes, Other End Users
3) By Application Type: Injectable Formulations, Vaccine Formulations, Cell Culture Or Bioprocessing, Diagnostic Formulations
Subsegments:
1) By Human Serum Albumin: 5% Human Serum Albumin, 20% Human Serum Albumin
2) By Recombinant Albumin: Recombinant Human Serum Albumin, Recombinant Bovine Serum Albumin
What Trends Are Affecting The Expansion Of The Albumin Excipient Market?
Leading companies operating within the albumin excipient market are implementing a strategic partnership approach to serve the crucial biotechnology and pharmaceutical sectors. Strategic partnerships denote a process where enterprises utilize each other’s capabilities and assets to secure shared benefits and achievements. For example, in October 2023, ARTES Biotechnology GmbH, a biotechnology company based in Germany, formed a partnership with Basic Pharma, a pharmaceutical company located in the Netherlands, to further recombinant protein production. This collaboration aims to enhance pharmaceutical recombinant protein production by streamlining the supply chain and shortening the time-to-market for new offerings.
Which Major Firms Influence Developments In The Albumin Excipient Market?
Major companies operating in the albumin excipient market are Albumin Therapeutics LLC, Biotest AG, CSL Behring, Grifols S.A., InVitria Inc., Octapharma AG, Kedrion Biopharma, LFB USA Inc., Baxter International Inc., Merck KGaA, Albumedix A/S, Bio Products Laboratory Ltd., Ventria Bioscience Inc., Novartis AG, China Biologic Products Holdings Inc., ProMetic Life Sciences Inc., Sanquin, Takeda Pharmaceutical Company Limited, FUJIFILM Irvine Scientific Inc., Shire Plc, Biopharma, Hualan Biological Engineering Inc., Shanghai RAAS Blood Products Co. Ltd.
Read the full albumin excipient market report here:
https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report
Which Region Is Forecast To Lead The Albumin Excipient Market In Terms Of Market Size?
North America was the largest region in the Albumin Excipient market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global albumin excipient market report during the forecast period. The regions covered in the albumin excipient market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Albumin Excipient Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10672&type=smp
Browse Through More Reports Similar to the Global Albumin Excipient Market 2026, By The Business Research Company
Albumin Excipient Market Report 2026
https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report
Albumin Market Report 2026
https://www.thebusinessresearchcompany.com/report/albumin-global-market-report
Alcohol Excipients Market Report 2026
https://www.thebusinessresearchcompany.com/report/alcohol-excipients-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model